Intraperitoneal chemotherapy with mitoxantrone in malignant ascites

This publication has 10 references indexed in Scilit:

• Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma
  European Journal of Surgical Oncology, 2002
• Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome
  European Journal of Surgical Oncology, 2001
• Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer
  European Journal of Surgical Oncology, 2000
• Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy
  Cancer, 2000
• Intraperitoneal chemotherapy in ovarian cancer
  Cancer Treatment Reviews, 2000
• The role of intraperitoneal chemotherapy in epithelial ovarian cancer
  International Journal of Gynecologic Cancer, 2000
• In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols
  Seminars in Surgical Oncology, 1998
• Evidence for Persistence of Mitoxantrone within the Peritoneal Cavity Following Intraperitoneal Delivery
  Gynecologic Oncology, 1993
• Intraperitoneal Chemotherapy and Immunotherapy
  Oncology Research and Treatment, 1991
• Malignant ascites: review of the literature, and an update on monoclonal antibody-targeted therapy
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1989